MedTrace Logo

Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients

NCT00699725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2010-12-07

No results posted yet for this study

Summary

Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treatment compliance (both NSAID and PPI), to evaluate the relationship between compliance and NSAID-associated GI events

Conditions

  • Compliance
  • Gastroprotector Therapy
  • Risk Factors

Sponsors & Collaborators

Principal Investigators

  • Javier Zapardiel · AstraZeneca Spain Medical Dept

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699725 on ClinicalTrials.gov